Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Research To Practice | Oncology Videos · Dr. Neil Love
February 8, 20231h 3m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Drs Michael Birrer and Kathleen Moore, including the following topics:
- Gynecologic Oncology
- Introduction (0:00)
- Ovarian Cancer
- PARP inhibitors as primary maintenance (8:11)
- PARP inhibitors for recurrent and metastatic disease (19:04)
- Antibody-drug conjugates: Mirvetuximab soravtansine; upifitamab rilsodotin (31:39)
- Endometrial Cancer
- Immunotherapy for metastatic disease (43:49)
- Selinexor as maintenance therapy (51:33)
- Other novel agents (56:52)
- Cervical Cancer
- Immunotherapy for metastatic disease and the antibody-drug conjugate tisotumab vedotin (1:01:00)